Search Press releases Keywords From To 2 Oct 2020 Disposals of own shares Read More 2 Oct 2020 Changes in UCB's Board of Directors Read More 25 Sep 2020 Disposals of own shares Read More 22 Sep 2020 UCB Achieves Important Regulatory Milestone for Bimekizumab Read More 11 Sep 2020 Disposals of own shares Read More 9 Sep 2020 Final Phase II Results for UCB’s Rozanolixizumab in Primary Immune Thrombocytopenia (ITP) Published in Blood Advances Read More Pagination First page Previous page Previous … Page 49 Page 50 Page 51 Page 52 Current page 53 Page 54 Page 55 Page 56 Page 57 … Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe
